$150 support for JNJ?
$150 was a popular area from April to July. Once it finally broke through, it went to its high for the year of $168. Even after a good earning report, JNJ has been on the decline since. It hopefully found support at $150. It stayed in the support range for two days and immediately had the bullish engulfing candle, a nice sign.
In addition, this same period had RSI dip below 30. Only other time this happened this year was in April and that lasted for less than 10 days.
JNJ appears to be getting crushed with all the other Big Pharma. Overreaction in my opinion. JNJ moved -10% in 18 days. That's a big move for a company like that. This is not a meme stock. This is, dare I say it, a blue chip stock.
I am not an attorney, accountant or financial advisor, nor am I holding myself out to be, and the information contained in this post is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation
In addition, this same period had RSI dip below 30. Only other time this happened this year was in April and that lasted for less than 10 days.
JNJ appears to be getting crushed with all the other Big Pharma. Overreaction in my opinion. JNJ moved -10% in 18 days. That's a big move for a company like that. This is not a meme stock. This is, dare I say it, a blue chip stock.
I am not an attorney, accountant or financial advisor, nor am I holding myself out to be, and the information contained in this post is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.